Fancg Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Fanconi Anemia Group G Protein | |
|---|---|
| Protein Name | Fanconi Anemia Group G Protein |
| Alternative Names | FANCG, XRCC9 |
| Molecular Weight | 70 kDa |
| Length | 622 amino acids |
| UniProt ID | [O43272](https://www.uniprot.org/uniprot/O43272) |
| Cellular Location | Nucleus |
FANCG (also known as XRCC9) is a critical component of the Fanconi Anemia (FA) DNA repair pathway. As a key scaffold protein, FANCG mediates protein-protein interactions essential for FA core complex assembly and interstrand DNA crosslink (ICL) repair. The FA pathway is essential for maintaining genomic stability, and its dysfunction leads to Fanconi Anemia - a devastating autosomal recessive disorder.
The FA-BRCA pathway coordinates the repair of DNA interstrand crosslinks (ICLs), which are among the most toxic DNA lesions:
Scaffold Function: FANCG contains multiple tetratricopeptide repeat (TPR) domains that mediate interactions with FANCA, FANCF, and other FA core complex proteins. These TPR domains form a protein-binding groove essential for complex assembly.
Complex Stabilization: FANCG stabilizes the entire FA core complex on chromatin. Studies show that FANCG directly binds to FANCA and FANCF, creating a network of protein interactions.
ICL Repair Initiation: The FANCG-containing complex recognizes ICLs and initiates the repair cascade, leading to FANCD2 monoubiquitination.
Homologous Recombination: Following ICL unhooking, FANCG coordinates the recruitment of BRCA1/2 for error-free homologous recombination repair.
FANCG is a 622 amino acid protein (70 kDa) with key structural features:
The TPR domains adopt a right-handed superhelical structure that provides a large interaction surface for multiple FA proteins.
DNA repair deficits are increasingly recognized in neurodegenerative diseases:
Modulating the FA pathway has therapeutic potential:
FANCG mutations cause Fanconi Anemia type G (FA-G):
FA-G patients typically present in childhood with bone marrow failure. Allogeneic stem cell transplantation remains the only curative option for hematological manifestations.
The study of Fancg Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.